JN
Jagiyassi Nirmala
About Jagiyassi Nirmala
Data last updated:
Jagiyassi Nirmala is a Director at Neocell Science Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Neocell Science Pharmaceuticals Private Limited reported revenue of ₹3.61 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Neocell Science Pharmaceuticals Private Limited U51909TG2019PTC135631 | Director | 23 Sep 2019 | 2019 | ₹3.61 Cr (FY 2024) | Active |
Board colleagues of Jagiyassi Nirmala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jagiyassi Harish Kumar | 08569900 | Neocell Science Pharmaceuticals Private Limited | Director |
| Nagaraju Nallagatla | 08569899 | Neocell Science Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jagiyassi Nirmala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jagiyassi Nirmala
Jagiyassi Nirmala currently holds 1 directorship: Neocell Science Pharmaceuticals Private Limited (Director, since 23 Sep 2019, revenue ₹3.61 Cr (FY 2024)).
Jagiyassi Nirmala was first appointed on 23 Sep 2019 as Director at Neocell Science Pharmaceuticals Private Limited.
The current boards of Jagiyassi Nirmala's companies include Jagiyassi Harish Kumar (Neocell Science Pharmaceuticals Private Limited), Nagaraju Nallagatla (Neocell Science Pharmaceuticals Private Limited).